Comparing the Fit and Performance of Scleral Lenses With Oval and Circular Limbal Zones
NCT ID: NCT07288658
Last Updated: 2025-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE4
7 participants
INTERVENTIONAL
2025-12-31
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
While these lenses offer many benefits, fitting them properly can be difficult, especially over the limbus, the border between the clear front surface of the eye and the white part of the eye. This area is home to important stem cells that help keep the eye healthy. Most lenses today are designed to fit the limbus as if it were perfectly round, but new research shows the limbus is actually more oval-shaped. When scleral lenses do not match this shape, they may press too hard in some areas or leave too much space in other areas of the limbus, potentially causing discomfort or long-term eye health problems.
This study will test whether lenses designed with an oval-shaped limbal zone provide a better fit and greater comfort than traditional round designs. To do this, advanced eye imaging and computer modelling will be used to measure the limbus and customize scleral lens design for each participant.
All lenses used in the study are already approved and available in Canada. The results may help improve lens comfort and safety for people who rely on scleral lenses every day.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Fitting scleral lenses, however, is not without challenges, and currently available scleral lens fitting strategies may not be adequate for the long-term needs of all patients. In particular, fitting of scleral lenses over the limbal area is known to be suboptimal. The limbus is the transitional area between the clear cornea and the white sclera. It contains numerous limbal stem cells crucial to maintaining long-term corneal health. Currently, the majority of contemporary scleral lens designs only involve a uniform circular-shaped area to fit over the limbus. However, several reports have recently shown that the human limbus is of an oval rather than a circular shape. Furthermore, there is currently limited information on the elevation/height of the limbal zone, including whether the height of the limbal zone is the same or different in each quadrant and whether this should be compensated for in lens design and fitting. The mismatch between the limbal zone design in a scleral lens and the true limbal shape leads to inappropriate fit of scleral lenses in the limbal area: typically, there can be excessive and inadequate clearance over the limbus in different parts of the same eye. Excessive and inadequate clearance both cause stress to the limbal stem cells, which is hypothesized to compromise patient comfort and risk the health of the cornea long-term.
To enhance lens comfort and minimize the risk of compromising ocular health, scleral lenses must be designed with an accurate understanding of the limbus's shape and dimensions. Achieving this requires a reliable and efficient method for capturing and analyzing limbal data. One such method involves a computational approach that uses Zernike polynomial-based modeling to identify limbal points on a corneoscleral topography scan, a technique previously validated on model eye scans. The proposed study will evaluate the performance of scleral lenses with oval versus circular limbal zones, using limbal width measurements obtained through a customized MATLAB program based on this method. The hypothesis is that when compared to scleral lenses designed with a standard, circular, non-customized limbal zone, scleral lenses with an oval limbal zone may result in more even limbal clearance 360, which leads to less corneal observations (e.g. corneal staining, corneal microcysts) related to scleral lens fit issues in the limbal area (e.g. limbal congestion, limbal touch, conjunctival prolapse), less lens decentration and better subjective comfort when worn.
The study lenses are marketed and commercially available in Canada.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Scleral lenses with an oval limbal zone
Scleral lenses with an oval limbal zone designed with a scleral lens custom design software (WAVE Contact Lens System)
Scleral lenses
Scleral lenses designed with oval and circular limbal zone designs
Scleral lenses with a circular limbal zone
Scleral lenses with a circular limbal zone designed with a scleral lens custom design software (WAVE Contact Lens System)
Scleral lenses
Scleral lenses designed with oval and circular limbal zone designs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scleral lenses
Scleral lenses designed with oval and circular limbal zone designs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have signed an information consent letter;
* Are willing and able to follow instructions and maintain the appointment schedule;
* Are existing wearers of WAVE ScleraLens in one or both eyes.
Exclusion Criteria
* Have any known active\* ocular disease and/or infection;
* Have known sensitivity to the diagnostic pharmaceuticals to be used in the study;
* Have taken part in another (pharmaceutical) research study within the last 30 days; \* For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and mild dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fighting Blindness Canada
UNKNOWN
Canadian Optometric Education Trust Fund (COETF)
UNKNOWN
University of Waterloo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lyndon Jones, PhD, FCOptom
Role: PRINCIPAL_INVESTIGATOR
University of Waterloo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Optometry & Vision Science, University of Waterloo
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lyndon Jones, PhD, FCOptom
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
47580
Identifier Type: -
Identifier Source: org_study_id